Stock Information
Bristol-Myers Squibb Co (BMY)
Ticker Symbol: BMY
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $127,014.86 mil
Piotroski score: 8
PE Ratio: 17.507
EPS (TTM): 3.4598
Revenue (TTM): $23.64 M
Dividend Yield: 4.3047488896481%
ROE: 39.28%
Latest News
-
Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note
Tue, Mar 31, 2026 9:45 PM
-
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates
Tue, Mar 31, 2026 8:55 PM
-
Camzyos Adolescent Trial Success Might Change The Case For Investing In Bristol-Myers Squibb (BMY)
Tue, Mar 31, 2026 3:06 PM
-
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Tue, Mar 31, 2026 1:00 PM
-
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
Tue, Mar 31, 2026 12:09 PM
-
Ariel Global Fund Re-Added Bristol-Myers Squibb Company (BMY) on Pipeline Strength and Attractive Valuation
Tue, Mar 31, 2026 12:04 PM
-
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players
Tue, Mar 31, 2026 11:32 AM
-
Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
Tue, Mar 31, 2026 10:59 AM
-
Will Positive Camzyos Data Strengthen BMY's Cardiovascular Portfolio?
Mon, Mar 30, 2026 6:59 PM
-
Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says
Mon, Mar 30, 2026 3:25 PM
Key Financials
Financial data not available